Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants
1
Centre for Inherited Metabolic Diseases, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden
2
Department of Medical Biochemistry and Biophysics, Division of Molecular Metabolism, Karolinska Institute, SE-171 77 Stockholm, Sweden
3
Department of Anesthesiology and Intensive Care, Mälarsjukhuset, SE-631 88 Eskilstuna, Sweden
4
LabSystems Diagnotics Oy, Tiilitie 3, FIN-01720 Vantaa, Finland
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2019, 5(4), 38; https://doi.org/10.3390/ijns5040038
Received: 23 September 2019
/
Revised: 25 October 2019
/
Accepted: 29 October 2019
/
Published: 29 October 2019
Sweden has 10.2 million inhabitants and more than 2.4 million have a foreign background. A substantial number of immigrants come from countries where glucose-6-phosphate dehydrogenase deficiency (G6PDD) is frequent. The total birth rate annually in Sweden is approximately 117,000 and newborn screening is centralized to one laboratory. We determined glucose-6-phosphate dehydrogenase (G6PD) activity in 10,098 dried blood spot samples (DBS) from the whole country with a fluorometric assay (LabSystems Diagnostics Oy, Finland). The first 5451 samples were anonymised and run as singletons, whilst the following 4647 samples were coded. Enzyme activity ≤40% of the mean of the day was found in 58 samples (1/170) and among these, 29 had activities ≤10% (1/350). Twenty-nine samples with residual activities between 2–39% in the coded cohort were subjected to Sanger sequencing. Disease-causing variants were identified in 26 out of 29 infants, of which six were girls. In three patients, we did not find any disease-causing variants, although two patients were hemizygous for the known polymorphisms c.1311T>C and c.1365-13C>T. The most common disease-causing variant found in 15 of the 29 samples (12 hemizygotes, two heterozygotes, one homozygote) was the Mediterranean mutation, c.563C>T (p.(Ser188Phe)) in exon 6. G6PDD is thus a surprisingly prevalent disorder in Sweden.
View Full-Text
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Ohlsson, A.; Rehnholm, K.; Shubham, K.; von Döbeln, U. Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants. Int. J. Neonatal Screen. 2019, 5, 38. https://doi.org/10.3390/ijns5040038
AMA Style
Ohlsson A, Rehnholm K, Shubham K, von Döbeln U. Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants. International Journal of Neonatal Screening. 2019; 5(4):38. https://doi.org/10.3390/ijns5040038
Chicago/Turabian StyleOhlsson, Annika, Katarina Rehnholm, Kumar Shubham, and Ulrika von Döbeln. 2019. "Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants" International Journal of Neonatal Screening 5, no. 4: 38. https://doi.org/10.3390/ijns5040038
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
